MRUS
Merus N.V. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +16.7% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.89M | +73.6% | $144.26M | 0.0% | ▲ Add | 2 | SEC ↗ ×8 |
| 2 | T. Rowe Price ✦ | 1.28M | -7.5% | $64.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Marshall Wace ✦ | 1.12M | +17.1% | $56.06M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | D. E. Shaw & Co. ✦ | 663.59K | +27.3% | $33.15M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Two Sigma Investments ✦ | 593.04K | -6.3% | $29.63M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Millennium Management ✦ | 472.38K | +94.2% | $23.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 219.22K | +20.6% | $10.95M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | Adage Capital Partners ✦ | 185.00K | -76.0% | $9.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 52.10K | -0.2% | $2.60M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 13.55K | +60.0% | $676,908 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.